These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4019705)

  • 21. Evaluation of some strategies for treating concomitant factors in randomized trials.
    Commenges D
    Methods Inf Med; 1986 Oct; 25(4):237-41. PubMed ID: 3773782
    [No Abstract]   [Full Text] [Related]  

  • 22. A two-stage trial design for testing treatment, self-selection and treatment preference effects.
    Rücker G
    Stat Med; 1989 Apr; 8(4):477-85. PubMed ID: 2727471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonparametric prediction of event times in randomized clinical trials.
    Ying GS; Heitjan DF; Chen TT
    Clin Trials; 2004; 1(4):352-61. PubMed ID: 16279273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accrual by groups in trials with discrete-time survival endpoints.
    Jóźwiak K; Moerbeek M
    Clin Trials; 2013 Feb; 10(1):32-42. PubMed ID: 23203992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal two-stage designs for clinical trials with binary response.
    Thall PF; Simon R; Ellenberg SS; Shrager R
    Stat Med; 1988 May; 7(5):571-9. PubMed ID: 3387716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transient state model for analysing ventilatory status in a randomized clinical trial.
    Jais JP; Chastang C; Raphael JC
    Stat Med; 1987; 6(7):795-803. PubMed ID: 3423501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategy and alternate randomized designs in cancer clinical trials.
    Zelen M
    Cancer Treat Rep; 1982 May; 66(5):1095-100. PubMed ID: 7083213
    [No Abstract]   [Full Text] [Related]  

  • 30. The relative efficiency of Zelen's prerandomization design for clinical trials.
    Anbar D
    Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Null results in clinical trials: the need for a decision-theory approach.
    Ciampi A; Till JE
    Br J Cancer; 1980 Apr; 41(4):618-29. PubMed ID: 6930301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of duration of response: a problem of oncology trials.
    Morgan TM
    Control Clin Trials; 1988 Mar; 9(1):11-8. PubMed ID: 3356149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical inference on censored data for targeted clinical trials under enrichment design.
    Chen CF; Lin JR; Liu JP
    Pharm Stat; 2013; 12(3):165-73. PubMed ID: 23606647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.
    Miller DR; Leikin S; Albo V; Vitale L; Sather H; Coccia P; Nesbit M; Karon M; Hammond D
    Cancer Treat Rep; 1980; 64(2-3):381-92. PubMed ID: 6931631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical inference and the design of clinical trials.
    Berry DA
    Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the hyperparameters of a prior probability model in survival analysis.
    Birch R; Bartolucci AA
    Comput Programs Biomed; 1983; 17(1-2):89-93. PubMed ID: 6362981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.
    Phadnis MA; Wetmore JB; Mayo MS
    Stat Med; 2017 Nov; 36(26):4121-4140. PubMed ID: 28815655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Group allocation by random procedure in field trial (Latin square in working out the list for random allocation) (author's transl)].
    Bencić Z
    Lijec Vjesn; 1981 Oct; 103(10):425-30. PubMed ID: 7341896
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.